A major German pharmaceutical corporation announced Monday that it has initiated legal proceedings in a New York courtroom targeting Johnson & Johnson and its subsidiary Janssen Biotech Inc.
Bayer revealed the lawsuit concerns disputes related to Nubeqa, the company’s treatment for prostate cancer patients.
The legal action was filed in New York court, though specific details about the nature of the dispute between the pharmaceutical giants were not immediately disclosed.
